top of page
Join date: Sep 27, 2020
Sep 28, 2023 ∙ 3 min
Key ceftobiprole data published
Basilea announced today that the data from the ceftobiprole Phase 3 trial in patients with Staphylococcus aureus (S. aureus) bacteraemia...
Aug 15, 2023 ∙ 3 min
Basilea - H1 results and upgrade
The continued growth of the Cresemba franchise, along with a planned reduction in R&D spending, has taken Basilea into a period of...
bottom of page